NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Pfizer logo
Pfizer, the international biopharmaceutical giant, is expanding its gene therapy program with the purchase of a Durham property that will become a clinical manufacturing facility.
Guy with flu
NIH has launched a massive effort to develop better flu vaccines, awarding the Duke Human Vaccine Institute three contracts worth up to $400 million over seven years.
CivaTech logo
RTP's CivaTech Oncology has received marketing approval from the FDA for its new CivaDerm skin cancer treatment "bandage."
Ribometrix logo
Durham's Ribometrix, started with funding help from NCBiotech, will partner with Vertex Pharmaceuticals of Boston to discover and develop drug candidates in a deal that could ultimately be worth more than $700 million to Ribometrix.
BioCryst logo
The U.S. Department of Health and Human Services has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceutical’s approved antiviral influenza therapy, RAPIVAV.
Funding panel
Knowledge is power. Work smarter not harder. Both principles drove the third annual Informing Innovation 2019 event hosted recently by the Life Science Intelligence team at the North Carolina Biotechnology Center.
Locus logo
Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, joins companies from the U.S., Belgium, the U.K. and Spain named to the prestigious "Fierce 15" listing of the world's hottest biotech companies.
Aerami's inhaler
Type 2 diabetes patients may soon have an option to inhale insulin through a device from Durham's Aerami Therapeutics that acts faster and lasts longer than Lilly’s injected insulin.
Novan logo
A $1.1 million U.S. Department of Defense grant will support Morrisville-based Novan’s efforts to develop a new defense against cervical cancer.
Plant Sciences Initiative building at NC State
Hanging on to North Carolina's dominance in agricultural technology requires continued investment and innovation, said panelists at the North Carolina Biotechnology Center’s September AgTech Professional Forum.
Mycovia logo
Durham’s Mycovia Pharmaceuticals has emerged as the winner over nine finalist life science startups from across the nation vying for recognition in the “Buzz of BIO” Late Stage Leaders competition, part of the BIO Investor Forum taking place in San Francisco in October. 
Lung Cancer Grant Logo
Applications for the Vicky Amidon Innovation Grant in Lung Cancer Research Award are due Oct. 1.
Ponytail ag logo
The NCBiotech Agriculture Sector Development team is partnering with local agriculture organizations to highlight women in agriculture across North Carolina.
Precision Biosciences logo
Precision BioSciences, a genome-editing company based in Durham, has received authorization from the U.S. Food and Drug Administration to advance its second genome-edited cancer therapy to clinical trials.  
Arbiom illustration
Durham-based Arbiom is challenging the world of animal feed by utilizing wood waste as a source of protein.